Alexandrescu S, Imamovic-Tuco A, Janeway K, Hanna J (2023) Clear cell tumor with melanocytic differentiation and MITF::CREM translocation. J Cutan Pathol 50:619–622. https://doi.org/10.1111/cup.14427
Cellier L, Perron E, Pissaloux D, Karanian M, Haddad V, Alberti L, de la Fouchardiere A (2018) Cutaneous melanocytoma with CRTC1-TRIM11 fusion: report of 5 cases resembling clear cell sarcoma. Am J Surg Pathol 42:382–391. https://doi.org/10.1097/PAS.0000000000000996
de la Fouchardiere A, Pissaloux D, Tirode F, Hanna J (2021) Clear cell tumor with melanocytic differentiation and MITF-CREM translocation: a novel entity similar to clear cell sarcoma. Virchows Arch 479:841–846. https://doi.org/10.1007/s00428-021-03027-3
Article CAS PubMed Google Scholar
de la Fouchardiere A, Pissaloux D, Tirode F, Karanian M, Fletcher CDM, Hanna J (2021) Clear cell tumor with melanocytic differentiation and ACTIN-MITF translocation: report of 7 cases of a novel entity. Am J Surg Pathol 45:962–968. https://doi.org/10.1097/PAS.0000000000001630
Hanna J, Ko JS, Billings SD, Boivin F, Beaudoux O, Pissaloux D, Tirode F, Laga A, Fletcher CDM, de la Fouchardiere A (2022) Cutaneous melanocytic tumor with CRTC1::TRIM11 translocation: an emerging entity analyzed in a series of 41 cases. Am J Surg Pathol 46:1457–1466. https://doi.org/10.1097/PAS.0000000000001952
Kalmykova A, Mosaieby E, Kacerovska D, Baranovska-Andrigo V, Martinek P, Smahova S, Michal M, Michal M (2023) MITF::CREM-rearranged tumor: a novel group of cutaneous tumors with melanocytic differentiation. Virchows Arch. https://doi.org/10.1007/s00428-023-03621-7
Ko JS, Wang L, Billings SD, Pissaloux D, Tirode F, Berry R, De La Fouchardiere A (2019) CRTC1-TRIM11 fusion defined melanocytic tumors: a series of four cases. J Cutan Pathol 46:810–818. https://doi.org/10.1111/cup.13533
Yang L, Yin Z, Wei J, Chai J, Zhao D, Liu Y, Tang Y, Cheng H, Zhe W, Fan L (2023) Cutaneous melanocytic tumour with CRTC1::TRIM11 fusion in a case with recurrent local lymph node and distant pulmonary metastases at early stage: aggressive rather than indolent? Histopathology 82:368–371. https://doi.org/10.1111/his.14812
Fischer GM, Papke DJ Jr (2023) Gene fusions in superficial mesenchymal neoplasms: emerging entities and useful diagnostic adjuncts. Semin Diagn Pathol 40:246–257. https://doi.org/10.1053/j.semdp.2023.04.014
Bertolotto C, Abbe P, Hemesath TJ, Bille K, Fisher DE, Ortonne JP, Ballotti R (1998) Microphthalmia gene product as a signal transducer in cAMP-induced differentiation of melanocytes. J Cell Biol 142:827–835. https://doi.org/10.1083/jcb.142.3.827
Article CAS PubMed PubMed Central Google Scholar
Price ER, Fisher DE (2001) Sensorineural deafness and pigmentation genes: melanocytes and the Mitf transcriptional network. Neuron 30:15–18. https://doi.org/10.1016/s0896-6273(01)00259-8
Article CAS PubMed Google Scholar
Ko JS, Lemahieu J, Billings SD, Tirode F, Payton D, Boone B, Pissaloux D, de la Fouchardiere A (2024) MED15::ATF1-rearranged tumor: a novel cutaneous tumor with melanocytic differentiation. Mod Pathol 37:100438. https://doi.org/10.1016/j.modpat.2024.100438
Fusumae T, Kamiya K, Maekawa T, Komine M, Murata S, Ohtsuki M (2018) Clear cell sarcoma with intraepidermal nests requiring the differential diagnosis of malignant melanoma. J Dermatol 45:115–116. https://doi.org/10.1111/1346-8138.13780
Kiuru M, Hameed M, Busam KJ (2013) Compound clear cell sarcoma misdiagnosed as a Spitz nevus. J Cutan Pathol 40:950–954. https://doi.org/10.1111/cup.12197
Luzar B, Billings SD, de la Fouchardiere A, Pissaloux D, Alberti L, Calonje E (2020) Compound Clear cell sarcoma of the skin-a potential diagnostic pitfall: report of a series of 4 new cases and a review of the literature. Am J Surg Pathol 44:21–29. https://doi.org/10.1097/PAS.0000000000001404
Kasago IS, Chatila WK, Lezcano CM, Febres-Aldana CA, Schultz N, Vanderbilt C, Dogan S, Bartlett EK, D’Angelo SP, Tap WD, Singer S, Ladanyi M, Shoushtari AN, Busam KJ, Hameed M (2023) Undifferentiated and dedifferentiated metastatic melanomas masquerading as soft tissue sarcomas: mutational signature analysis and immunotherapy response. Mod Pathol 36:100165. https://doi.org/10.1016/j.modpat.2023.100165
Article PubMed PubMed Central Google Scholar
Bontoux C, Baroudjian B, Le Maignan C, Vercellino L, Farges C, Guillemot D, Pierron G, Lebbe C, Battistella M (2019) CRTC1-TRIM11 fusion in a case of metastatic clear cell sarcoma: are CRTC1-TRIM11 fusion-bearing tumors melanocytomas or clear cell sarcomas? Am J Surg Pathol 43:861–863. https://doi.org/10.1097/PAS.0000000000001217
Tseng C, Hein ECK, Smith SM, King I, Saibil S, Saeed Kamil Z (2024) Ulcerated CRTC1::TRIM11 cutaneous tumor with metastases. J Cutan Pathol. https://doi.org/10.1111/cup.14669
Vest BE, Berrebi KG, Stone MS, Sargen MR, Gerami P (2024) CRTC1::TRIM11 cutaneous tumor: an update with local recurrence and lung metastasis in a pediatric patient. J Cutan Pathol 51:181–183. https://doi.org/10.1111/cup.14556
Hanna J, Russell-Goldman E, Baranov E, Pissaloux D, Li YY, Tirode F, de la Fouchardiere A, Fletcher CDM (2024) PEComa with MITF overexpression: clinicopathologic and molecular analysis of a series of 36 cases. Am J Surg Pathol. https://doi.org/10.1097/PAS.0000000000002276
De Noon S, Flanagan AM, Tirabosco R, O’Donnell P, Amary F (2021) EWSR1-SMAD3 fibroblastic tumour of bone: expanding the clinical spectrum. Skeletal Radiol 50:445–450. https://doi.org/10.1007/s00256-020-03563-0
Habeeb O, Korty KE, Azzato EM, Astbury C, Farkas DH, Ko JS, Billings SD (2021) EWSR1-SMAD3 rearranged fibroblastic tumor: case series and review. J Cutan Pathol 48:255–262. https://doi.org/10.1111/cup.13870
Kao YC, Flucke U, Eijkelenboom A, Zhang L, Sung YS, Suurmeijer AJH, Antonescu CR (2018) Novel EWSR1-SMAD3 gene fusions in a group of acral fibroblastic spindle cell neoplasms. Am J Surg Pathol 42:522–528. https://doi.org/10.1097/PAS.0000000000001002
Article PubMed PubMed Central Google Scholar
Michal M, Berry RS, Rubin BP, Kilpatrick SE, Agaimy A, Kazakov DV, Steiner P, Ptakova N, Martinek P, Hadravsky L, Michalova K, Szep Z, Michal M (2018) EWSR1-SMAD3-rearranged fibroblastic tumor: an emerging entity in an increasingly more complex group of fibroblastic/myofibroblastic neoplasms. Am J Surg Pathol 42:1325–1333. https://doi.org/10.1097/PAS.0000000000001109
Friedman BJ (2021) Pitfall regarding expression of ETS-related gene (ERG) in fibrohistiocytic neoplasms. J Cutan Pathol 48:1003–1004. https://doi.org/10.1111/cup.14024
Anderson WJ, Mertens F, Marino-Enriquez A, Hornick JL, Fletcher CDM (2022) Superficial CD34-positive fibroblastic tumor: a clinicopathologic, immunohistochemical, and molecular study of 59 cases. Am J Surg Pathol 46:1329–1339. https://doi.org/10.1097/PAS.0000000000001927
Carter JM, Weiss SW, Linos K, DiCaudo DJ, Folpe AL (2014) Superficial CD34-positive fibroblastic tumor: report of 18 cases of a distinctive low-grade mesenchymal neoplasm of intermediate (borderline) malignancy. Mod Pathol 27:294–302. https://doi.org/10.1038/modpathol.2013.139
Article CAS PubMed Google Scholar
Lao IW, Yu L, Wang J (2017) Superficial CD34-positive fibroblastic tumour: a clinicopathological and immunohistochemical study of an additional series. Histopathology 70:394–401. https://doi.org/10.1111/his.13088
Perret R, Michal M, Carr RA, Velasco V, Svajdler M, Karanian M, Meurgey A, Paindavoine S, Soubeyran I, Coindre JM, Boidot R, Charon-Barra C, Geneste D, Weingertner N, Pissaloux D, Tirode F, Baud J, Le Loarer F (2021) Superficial CD34-positive fibroblastic tumor and PRDM10-rearranged soft tissue tumor are overlapping entities: a comprehensive study of 20 cases. Histopathology 79:810–825. https://doi.org/10.1111/his.14429
Puls F, Carter JM, Pillay N, McCulloch TA, Sumathi VP, Rissler P, Fagman H, Hansson M, Amary F, Tirabosco R, Magnusson L, Nilsson J, Flanagan AM, Folpe AL, Mertens F (2022) Overlapping morphological, immunohistochemical and genetic features of superficial CD34-positive fibroblastic tumor and PRDM10-rearranged soft tissue tumor. Mod Pathol 35:767–776. https://doi.org/10.1038/s41379-021-00991-8
留言 (0)